scispace - formally typeset
L

Li Liu

Researcher at Huazhong University of Science and Technology

Publications -  64
Citations -  2552

Li Liu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 16, co-authored 51 publications receiving 1826 citations.

Papers
More filters
Journal ArticleDOI

Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.

TL;DR: A series of multifaceted public health interventions was temporally associated with improved control of the COVID-19 outbreak in Wuhan, China, and may inform public health policy in other countries and regions.
Posted ContentDOI

Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China

TL;DR: Considerable countermeasures have effectively controlled the Covid-19 outbreak in Wuhan, China, and special efforts are needed to protect vulnerable populations, including healthcare workers, elderly and children.
Journal ArticleDOI

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade.

TL;DR: Identification of comutations in specific DDR pathways as predictors of superior survival outcomes in response to immune checkpoint blockade provide a clinically convenient approach for estimation of tumor mutational burden and delivery of ICB therapy.
Journal ArticleDOI

Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

Mitchell J. Machiela, +133 more
TL;DR: The results indicate that a genetic background that favors longer telomere length may increase lung cancer risk, which is consistent with earlier prospective studies relating longer telomerre length with increased lung cancerrisk.
Journal ArticleDOI

Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

TL;DR: Del-NOTCHmut exhibited better predictive function than non-deleterious NOTCH mutation, potentially via greater transcription of genes related to DNA damage response and immune activation, and was independently associated with immunotherapeutic benefit.